TITLE

Bleeding during critical illness: A prospective cohort study using a new measurement tool

AUTHOR(S)
Arnold, Donald M.; Donahoe, Laura; Clarke, France J.; Tkaczyk, Andrea J.; Heels-Ansdell, Diane; Zytaruk, Nicole; Cook, Richard; Webert, Kathryn E.; McDonald, Ellen; Cook, Deborah J.
PUB. DATE
April 2007
SOURCE
Clinical & Investigative Medicine;Apr2007, Vol. 30 Issue 2, pE93
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Purpose: To estimate the incidence, severity, duration and consequences of bleeding during critical illness, and to test the performance characteristics of a new bleeding assessment tool. Methods: Clinical bleeding assessments were performed prospectively on 100 consecutive patients admitted to a medical-surgical intensive care unit (ICU) using a novel bleeding measurement tool called HEmorrhage MEasurement (HEME). Bleeding assessments were done daily in duplicate and independently by blinded, trained assessors. Inter-rater agreement and construct validity of the HEME tool were calculated using Φ. Risk factors for major bleeding were identified using a multivariable Cox proportional hazards model. Results: Overall, 90% of patients experienced a total of 480 bleeds of which 94.8% were minor and 5.2% were major. Inter-rater reliability of the HEME tool was excellent (Φ = 0.98, 95% CI: 0.96 to 0.99). A decrease in platelet count and a prolongation of partial thromboplastin time were independent risk factors for major bleeding but neither were renal failure nor prophylactic anticoagulation. Patients with major bleeding received more blood transfusions and had longer ICU stays compared to patients with minor or no bleeding. Conclusions: Bleeding, although primarily minor, occurred in the majority of ICU patients. One of five patients experienced a major bleed which was associated with abnormal coagulation tests but not with prophylactic anticoagulants. These baseline bleeding rates can inform the design of future clinical trials in critical care that use bleeding as an outcome and HEME is a useful tool to measure bleeding in critically ill patients.
ACCESSION #
25385126

 

Related Articles

  • Ageas Protect enters business protection sector. Thomas, Paul // Money Marketing (Online Edition);5/1/2013, p13 

    The article reports on the launch of a new business protection product range by Ageas Protect in Great Britain. The purpose of the product is to provide businesses with financial support if a crucial member of their company dies or becomes critically ill. The company will offer term assurance or...

  • Mannose-binding lectin deficiency provides a genetic basis for the use of SIRS/sepsis definitions in critically ill patients. Carcillo, Joseph A. // Intensive Care Medicine;Jul2004, Vol. 30 Issue 7, p1263 

    The article cites a study, which reveals that mannose-binding lectin deficiency provides a genetic basis for the use of systemic inflammatory response syndrome (SIRS) definitions in critically ill patients. Over a decade ago, the medical scientist Roger Bone developed clinical criteria to...

  • The transpulmonary thermodilution technique. Sakka, Samir; Reuter, Daniel; Perel, Azriel // Journal of Clinical Monitoring & Computing;Oct2012, Vol. 26 Issue 5, p347 

    The transpulmonary thermodilution technique (TPTD) is a safe, multi-parametric advanced cardiopulmonary monitoring technique that provides important parameters required for making decisions in critically ill patients. The TPTD provides more reliable indicators of preload than filling pressures,...

  • Soluble receptor for advanced glycation end products in critically ill patients and its associations with other clinical markers and 28-day mortality. Yanzi Cheng; Jiwen Zhong; Yang Xiang; Fan Zeng; Dehong Cai; Ling Zhao // Clinical Interventions in Aging;2014, Vol. 9, p1981 

    Purpose: To investigate the possible associations between serum levels of soluble receptor for advanced glycation end products (sRAGE) and specific clinical markers and prognosis in critically ill patients diagnosed with stress hyperglycemia. Patients and methods: A total of 70 critically ill...

  • Assessment of left ventricular ejection fraction using an ultrasonic stethoscope in critically ill patients.  // Critical Care;2012, Vol. 16 Issue 1, pR29 

    The article presents a study on the assessment of left ventricular ejection fraction (LEVF) using an ultrasonic stethoscope in critically ill patients. In the study, a total of 94 consecutive patients were studied, 63 being mechanically ventilated and 36 receiving vasopressors and/or inotropes....

  • critical. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p204 

    A definition of the term "critical" is presented. It refers to a seriously ill condition or a crucial state of illness from which a patient may not recover.

  • Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration. Olaf Burkhardt; Vipul Kumar; Denise Katterwe; Jolanta Majcher-Peszynska; Bernd Drewelow; Hartmut Derendorf; Tobias Welte // Journal of Antimicrobial Chemotherapy (JAC);Feb2007, Vol. 59 Issue 2, p277 

    Objectives Most information about pharmacokinetics of antimicrobial agents is obtained from studies in healthy volunteers. However, antibiotics are therapeutically used in infected patients with very different pharmacokinetic properties compared with healthy individuals. ...

  • The Clinical Significance of Weight Change in Mechanical Ventilated, Critically Ill Patients of ICU. Young Sun Seo; You Eun Kim; Seung Jun Lee; Yu Ji Cho; Yi Yeong Jeong; Ho Cheol Kim; Jong Deok Lee; Young Sil Hwang // Korean Journal of Critical Care Medicine;2011, Vol. 26 Issue 3, p139 

    BACKGROUND: Critically ill patients may show significant weight change in their course of disease during ICU stay. However, what weight changes occur and their effects on patient outcome have not yet been reported to our knowledge. Therefore, we evaluated weight change in critically ill patients...

  • Pseudomonas aeruginosa serotypes in nosocomial pneumonia: prevalence and clinical outcomes. Qin Lu; Eggimann, Philippe; Luyt, Charles-Edouard; Wolff, Michel; Tamm, Michael; François, Bruno; Mercier, Emmanuelle; Garbino, Jorge; Laterre, Pierre-François; Koch, Holger; Gafner, Verena; Rudolf, Michael P.; Mus, Erkan; Perez, Antonio; Lazar, Hedvika; Chastre, Jean; Rouby, Jean-Jacques // Critical Care;2014, Vol. 18 Issue 1, p1 

    Introduction Pseudomonas aeruginosa frequently causes nosocomial pneumonia and is associated with poor outcome. The purpose of this study was to assess the prevalence and clinical outcome of nosocomial pneumonia caused by serotype specific Pseudomonas aeruginosa in critically ill patients under...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics